Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 10 de 10
Filtrar
1.
Braz. j. pharm. sci ; 52(3): 527-544, July-Sept. 2016. tab, graf
Artículo en Inglés | LILACS | ID: biblio-828267

RESUMEN

ABSTRACT The skin barrier function has been attributed to the stratum corneum and represents a major challenge in clinical practice pertaining to cutaneous administration of drugs. Despite this, a large number of bioactive compounds have been successfully administered via cutaneous administration because of advances in the design of topical and transdermal formulations. In vitro and in vivo evaluations of these novel drug delivery systems are necessary to characterize their quality and efficacy. This review covers the most well-known methods for assessing the cutaneous absorption of drugs as an auxiliary tool for pharmaceutical formulation scientists in the design of drug delivery systems. In vitro methods as skin permeation assays using Franz-type diffusion cells, cutaneous retention and tape-stripping methods to study the cutaneous penetration of drugs, and in vivo evaluations as pre-clinical pharmacokinetic studies in animal models are discussed. Alternative approaches to cutaneous microdialysis are also covered. Recent advances in research on skin absorption of drugs and the effect of skin absorption enhancers, as investigated using confocal laser scanning microscopy, Raman confocal microscopy, and attenuated total reflectance Fourier-transform infrared spectroscopy, are reviewed.


Asunto(s)
Absorción Cutánea/efectos de los fármacos , Preparaciones Farmacéuticas/administración & dosificación , Absorción Cutánea/efectos de los fármacos , Absorción Cutánea/inmunología
2.
Indian J Dermatol Venereol Leprol ; 2013 Nov-Dec; 79(6): 759-771
Artículo en Inglés | IMSEAR | ID: sea-154675

RESUMEN

Acitretin, a synthetic retinoid has gradually replaced etretinate in today’s dermatologic practice because of its more favorable pharmacokinetics. Acitretin over the past 20 years has proven useful in a number of diffi cult-to-treat hyperkeratotic and infl ammatory dermatoses and nonmelanoma skin cancers. It is effective both as monotherapy and in combination with other drugs for hyperkeratotic disorders. It is considered to be an established second line treatment for psoriasis and exerts its effect mainly due to its antikeratinizing, antiinfl ammatory, and antiproliferative effect. Its antineoplastic properties make it a useful agent for cancer prophylaxis. Evidence-based effi cacy, side-effect profi le, and approach to the use of acitretin would be discussed in this review. In addition to its approved uses, the various off label uses will also be highlighted in this section. Since its use is limited by its teratogenic potential and other adverse effects, including mucocutaneous effects and hepatotoxicity, this review would summarize the contraindications and precautions to be exercised before prescribing acitretin.


Asunto(s)
Acitretina/administración & dosificación , Acitretina/farmacocinética , Animales , Antineoplásicos/administración & dosificación , Antineoplásicos/farmacocinética , Diferenciación Celular/efectos de los fármacos , Diferenciación Celular/fisiología , Dermatología/métodos , Dermatología/tendencias , Humanos , Queratolíticos/administración & dosificación , Queratolíticos/farmacocinética , Lesiones Precancerosas/patología , Lesiones Precancerosas/prevención & control , Absorción Cutánea/efectos de los fármacos , Absorción Cutánea/fisiología , Enfermedades de la Piel/tratamiento farmacológico , Enfermedades de la Piel/patología
3.
MEAJO-Middle East African Journal of Ophthalmology. 2013; 20 (1): 92-94
en Inglés | IMEMR | ID: emr-146702

RESUMEN

In this case report, we document a 54-year-old woman with total bilateral optic nerve atrophy after local application of methanol containing spirit. Almost all the reported cases of methanol intoxication in the literature are caused by oral ingestion. In this rare case, we present transdermal absorption of methanol that may cause irreversible blindness in addition to intracerebral lesions


Asunto(s)
Humanos , Femenino , Metanol/toxicidad , Absorción Cutánea/efectos de los fármacos , Solventes/efectos adversos , Ceguera , Tomografía Computarizada por Rayos X , Tonometría Ocular , Imagen por Resonancia Magnética
4.
Pakistan Journal of Pharmaceutical Sciences. 2011; 24 (4): 451-457
en Inglés | IMEMR | ID: emr-137543

RESUMEN

In the present study a new alcohol derivative of tetrahydrogeraniol [THG], an acyclic monoterpene, has been prepared by using Grignard reagent and methyl cyclopropyl ketone. Penetration enhancing effects of THG and the synthesized derivative 5,9-dimethyl-2-cyclopropyl-2-decanol [DICNOL] on the transdermal penetration of 5-fluorouracil [5-FU] and tramadol hydrochloride [tramadol HC1] across the excised rat skin were studied by an in vitro permeation technique using Franz diffusion cells. Azone was used as standard enhancer for comparison. DICNOL and THG significantly enhanced 5-FU and tramadol HC1 penetration through rat skin compared with the control. DICNOL enhanced the permeability of 5-FU and tramadol HC1 across full thickness skin by about 11 and 20 fold, respectively. Increased partition coefficient and diffusion coefficient values were obtained by these enhancers. The results suggest that the amount of DICNOL in the skin, especially in the stratum corneum, may be related to its penetration enhancing effects


Asunto(s)
Animales de Laboratorio , Masculino , Alcoholes Grasos/farmacocinética , Alcoholes Grasos/síntesis química , Absorción Cutánea/efectos de los fármacos , Terpenos/química , Adyuvantes Farmacéuticos , Terpenos/farmacología , Ratas Sprague-Dawley , Piel/efectos de los fármacos , Piel/metabolismo , Estudios de Evaluación como Asunto , Estructura Molecular , Permeabilidad/efectos de los fármacos , Preparaciones Farmacéuticas , Tramadol/metabolismo
5.
Pakistan Journal of Pharmaceutical Sciences. 2010; 23 (1): 83-88
en Inglés | IMEMR | ID: emr-93412

RESUMEN

local anesthesia of the intact skin is difficult because of the barrier properties of skin to epicutaneous penetration of local anesthetic drugs. Using local anesthetics with combination of penetration enhancers could overcome this problem. The main objective of this study was to assess the effects of some permeability enhancers on the percutaneous permeation of lidocaine. The effect of polysorbate 80, polysorbate 20, dimethylsulfoxide [DMSO], tert-butyl cyclohexanol [TBCH], and a-terpinol in different concentrations and various ratios of lidocaine to enhancers was evaluated. The results showed that polysorbate 80 and polysorbate 20 has no detectable penetration enhancing effects in guinea pig skin mounted to diffusion cells. The same results were obtained to water/oil] ratio and the type of oil phase [liguid paraffin vs. castor oil]. Addition of DMSO to the previous formulations had a comiderable enhancing effect According to the data, the extent of lidocaine permeation was proportional to me concentration of DMSO in fAese formulations. The best results belonged to the addition of terpenes but interestingly there wasn't any linear relationship between the concentrations of alpha terpinol/ or TBCH and the duration of antinociceptive effects of lidocaine. Based on the results of this study the ratio of 1: 4 from a- terpinol or TBCH to lidocaine results in a better antinociceptive effect and a- terpinol was the best one among of these compounds. This effect was proven with in vivo tail-immersion test to assess the antinociceptive effect of formulations which have shown more penetration


Asunto(s)
Animales , Permeabilidad/efectos de los fármacos , Absorción Cutánea/efectos de los fármacos , Anestésicos Locales/farmacocinética , Administración Cutánea , Interacciones Farmacológicas , Ratas , Piel/efectos de los fármacos
6.
Journal of Korean Medical Science ; : 766-771, 2010.
Artículo en Inglés | WPRIM | ID: wpr-157571

RESUMEN

Increased transepidermal water loss (TEWL) and downregulated antimicrobial peptides (AMPs) are observed in patients with atopic dermatitis (AD). Tacrolimus and ceramide-dominant emollients are effective in the treatment of AD by preventing the production of inflammatory cytokines and by correcting skin barrier dysfunctions, respectively. Present study was designed to investigate the relationship between antimicrobial and barrier factors by measuring the changes of AMPs and TEWL after topical application of tacrolimus and ceramide-dominant emollient in the patients with AD. A total of three patients with AD were treated with tacrolimus in one lesion and ceramide-dominant emollient in another lesion for 4 weeks. RT-PCR and western blotting revealed that the mRNA and protein expression levels of hBD-2 and LL-37 were increased on the both study sites. Immunohistochemical analysis showed significant increase of AMPs and IL-1alpha, while, IL-4 was decreased on the both study sites. The mean changes of TEWL and AMPs showed no statistical difference between both sites. Tacrolimus and ceramide-dominant emollient influence on both TEWL and AMPs expression in patients with AD, namely they have similar effects on both of the two. This study shows that restoration of permeability barrier function is accompanied by the concomitant improvement of antimicrobial defense in patients with AD.


Asunto(s)
Adolescente , Femenino , Humanos , Masculino , Adulto Joven , Administración Tópica , Péptidos Catiónicos Antimicrobianos/metabolismo , Ceramidas/administración & dosificación , Dermatitis Atópica/tratamiento farmacológico , Emolientes/administración & dosificación , Inmunosupresores/administración & dosificación , Absorción Cutánea/efectos de los fármacos , Tacrolimus/administración & dosificación , Resultado del Tratamiento , Pérdida Insensible de Agua/efectos de los fármacos
7.
Indian J Dermatol Venereol Leprol ; 2007 Sep-Oct; 73(5): 326-9
Artículo en Inglés | IMSEAR | ID: sea-51976

RESUMEN

BACKGROUND: Topical retinoids normalize desquamation, reduce comedogenesis and may enhance the penetration of other topicals providing more effective treatment of acne. AIM: We evaluated the effect of adapalene on skin penetration of clindamycin phosphate when it is applied concomitantly or after various time durations following adapalene application. METHODS: The in vitro studies were carried out using excised rat skin, whereas the in vivo studies were conducted on healthy human volunteers. Radioactive clindamycin phosphate (1%) gel was applied to rat skin sections and to the hands of human volunteers concomitantly and after the pretreatment of the skin for 3, 5 and 10 min with 10 mg of adapalene (0.1%) gel. Quantification of clindamycin phosphate was performed by liquid scintillation. RESULTS: In vitro skin penetration and distribution of clindamycin phosphate was affected by the pretreatment time. Significantly higher skin concentration of clindamycin phosphate (15.5%) with largest proportion in viable skin layer (9.4% of applied dose) was found when clindamycin phosphate gel was applied after the pretreatment of the skin with adapalene gel for 5 min. Further increase in pretreatment time has no additive influence on the penetration of clindamycin phosphate. In vivo results were in corroboration with the in vitro results and demonstrate significantly higher concentration of clindamycin phosphate (19%) in the skin following pretreatment with adapalene gel for 5 min. Adapalene acts as a penetration enhancer and increases the penetration of topical clindamycin phosphate. CONCLUSION: Application of clindamycin phosphate gel after the pretreatment of skin with adapalene gel for 5 min may contribute significantly to the increased efficacy of therapy.


Asunto(s)
Administración Tópica , Adulto , Animales , Antibacterianos/farmacocinética , Clindamicina/análogos & derivados , Quimioterapia Combinada , Humanos , Queratolíticos/farmacología , Masculino , Naftalenos/farmacología , Ratas , Absorción Cutánea/efectos de los fármacos , Pertecnetato de Sodio Tc 99m/diagnóstico
8.
Indian J Dermatol Venereol Leprol ; 2005 May-Jun; 71(3): 170-4
Artículo en Inglés | IMSEAR | ID: sea-52414

RESUMEN

BACKGROUND AND AIMS: Topical glucocorticoid formulations are widely used for effective treatment and control of a variety of dermatoses. Mometasone furoate is a newer corticoid that has high potency but low systemic toxicity. Pharmaceutical factors are known to significantly influence potency and systemic absorption of topically applied glucocorticoids. We studied the potency of "Elocon", a topical formulation of mometasone furoate, compared with two other branded formulations of the same corticoid. METHODS: Corticoid potency was measured by employing a pharmacodynamic parameter of an inhibitory effect of the corticoid on post-ischemic-reactive-hyperemic-response (PIRHR) in human forearm skin under occlusive dressing. The PIRHR was expressed in terms of % increase in the skin blood flow (SBF) as measured with laser doppler velocimetry (LDV). RESULTS : All three active branded formulations of mometasone furoate produced significant inhibition of PIRHR. The AUC(0-2 min) of PIRHR was ( Mean +/- SEM ), Control = 213.52 +/- 11.80, Placebo = 209.77 +/- 19.31, Formulation A = 119.83 +/- 13.71, Formulation C = 53.67 +/- 4.85 and Formulation D = 111.46 +/- 22.87. Formulation "C" exhibited significantly higher topical anti-inflammatory potency than formulations "A" or "D". CONCLUSIONS: Thus, branded formulations of the same glucocorticoid, mometasone furoate significantly differed in their topical anti-inflammatory potency. "Elocon" was significantly more potent than the two other branded formulations studied.


Asunto(s)
Administración Tópica , Adulto , Análisis de Varianza , Área Bajo la Curva , Química Farmacéutica , Femenino , Antebrazo , Glucocorticoides/administración & dosificación , Humanos , Flujometría por Láser-Doppler , Masculino , Pregnadienodioles/administración & dosificación , Valores de Referencia , Sensibilidad y Especificidad , Método Simple Ciego , Piel/efectos de los fármacos , Absorción Cutánea/efectos de los fármacos
9.
Indian J Exp Biol ; 2001 Jan; 39(1): 47-51
Artículo en Inglés | IMSEAR | ID: sea-59413

RESUMEN

Effect of penetration enhancers were studied on the permeation of antihypertensive drugs prazosin hydrochloride and atenolol through full thickness skin of swiss albino mice. Atenolol was delivered to skin from saturated alcoholic solution containing 5% of 1-decanol and alcohol alone, while prazosin hydrochloride was saturated in dimethyl formamide(DMF, 5% v/v in water) and dimethyl sulfoxide(DMSO, 5% v/v in water). Atenolol permeation was augmented significantly in decanolic solution and also in pure alcohol. In case of prazosin hydrochloride, significant enhancement of permeation was shown by DMSO but not by DMF.


Asunto(s)
Administración Cutánea , Animales , Atenolol/administración & dosificación , Dimetilsulfóxido/administración & dosificación , Dimetilformamida/administración & dosificación , Etanol/administración & dosificación , Alcoholes Grasos/administración & dosificación , Ratones , Prazosina/administración & dosificación , Absorción Cutánea/efectos de los fármacos
10.
Indian J Exp Biol ; 2000 Sep; 38(9): 895-900
Artículo en Inglés | IMSEAR | ID: sea-63119

RESUMEN

This study was designed to investigate the influence of volatile oil pretreated skin on in vitro permeation from films containing ionized and dodecylamine ion-paired diclofenac sodium (DS). The involvement of skin cholesterol was investigated to determine its possible role in enhancing the permeation of ion-paired DS. Cardamom oil produced the maximum (10 x) in vitro permeation enhancement for ion-paired DS. The carrageenan induced rat paw oedema reduction (up to 12 hr) by cardamom oil was comparable to that of diclofenac injection (s c). Leaching of cholesterol from excised skin in addition to increased partition coefficient following volatile oil skin pretreatment appears to be responsible for in vitro permeation enhancement of DS. Whereas, a mild barrier perturbation effect due to altered cholesterol levels following pretreatment with volatile oils appears to increase the permeation of ion-paired DS across viable skin, thereby producing significant reduction of carrageenan induced paw oedema.


Asunto(s)
Administración Cutánea , Animales , Antiinflamatorios no Esteroideos/farmacocinética , Biomarcadores/análisis , Colesterol/metabolismo , Diclofenaco/farmacocinética , Edema/inducido químicamente , Epidermis/metabolismo , Masculino , Aceites Volátiles/farmacología , Permeabilidad , Ratas , Ratas Endogámicas , Ratas Wistar , Piel/metabolismo , Absorción Cutánea/efectos de los fármacos , Solubilidad , Vehículos Farmacéuticos/farmacocinética
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA